A Master Protocol to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (TRIUMPH-1)
This study is testing an investigational medication called retatrutide to see if it safely helps people with obesity or overweight lose weight. Researchers also want to see how the study drug affects related health conditions like knee joint pain and sleep breathing issues.
You may be able to join if you do not have diabetes, have a higher body weight or body mass index, and meet certain health criteria like having high blood pressure or high cholesterol. People who have recently used weight loss medications, had weight loss surgery, or have a history of specific rare thyroid tumors cannot participate.
Participants will take either the study medication or a placebo, which looks like the medicine but has no active ingredients, once a week. The study lasts for about 89 weeks with up to 24 visits to monitor your health, weight, and overall well-being.
This study has locations in places like Arizona and Arkansas in the United States. The study status is currently completed.
- 1Testing a weekly investigational medication called retatrutide for weight management
- 2Lasts about 89 weeks with up to 24 clinic visits
- 3Open to adults with overweight or obesity who do not have diabetes
Related video
Related links
Outside pages about this study, checked by our team
This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.